PUBLIC COMPANY
saveSinoMab Bioscience Ltd
updated 2mo ago
community read0 votes
pipeline
2
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Preclinical1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1A Clinical Study to Evaluate SM17 in Healthy Participants
- phase2A Clinical Study to Evaluate SM17 for Atopic Dermatitis
- phase1A Phase I Clinical Study to Evaluate SM17 in Chinese Healthy Subjects and Patients With Moderate to Severe Atopic Dermatitis
- phase1A Phase 1 Study of Single and Multiple Intravenous Doses of SM17 in Healthy Subjects
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that